X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35) 35
index medicus (31) 31
female (30) 30
nuclear medicine (30) 30
middle aged (29) 29
life sciences (24) 24
adult (22) 22
breast cancer (22) 22
aged (19) 19
oncology (18) 18
prognosis (18) 18
chemotherapy (16) 16
[ sdv.ib.mn ] life sciences [q-bio]/bioengineering/nuclear medicine (15) 15
bioengineering (15) 15
cancer (15) 15
fluorodeoxyglucose f18 (15) 15
male (15) 15
positron-emission tomography (14) 14
lymphomas (12) 12
medicine & public health (12) 12
predictive value of tests (12) 12
tomography (12) 12
pet imaging (11) 11
positron-emission-tomography (10) 10
radiopharmaceuticals (10) 10
treatment outcome (10) 10
cardiology (9) 9
imaging / radiology (9) 9
orthopedics (9) 9
tomography, x-ray computed (9) 9
[sdv.can]life sciences [q-bio]/cancer (8) 8
aged, 80 and over (8) 8
breast neoplasms - diagnostic imaging (8) 8
breast neoplasms - pathology (8) 8
positron emission tomography (8) 8
radiology, nuclear medicine & medical imaging (8) 8
sensitivity and specificity (8) 8
breast neoplasms - drug therapy (7) 7
lymphoma (7) 7
medical imaging (7) 7
medical prognosis (7) 7
positron-emission tomography - methods (7) 7
reproducibility of results (7) 7
retrospective studies (7) 7
tumors (7) 7
adolescent (6) 6
analysis (6) 6
biopsy (6) 6
hematology (6) 6
multimodal imaging (6) 6
patients (6) 6
pet (6) 6
survival (6) 6
survival analysis (6) 6
glucose metabolism (5) 5
lung cancer (5) 5
neoplasm staging (5) 5
prospective studies (5) 5
response assessment (5) 5
rituximab (5) 5
roc curve (5) 5
therapy (5) 5
tumor burden (5) 5
angiogenesis (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
breast neoplasms - diagnosis (4) 4
care and treatment (4) 4
cyclophosphamide (4) 4
diagnosis (4) 4
diffuse large b-cell lymphoma (4) 4
disease-free survival (4) 4
follow-up studies (4) 4
glucose (4) 4
metabolism (4) 4
multivariate analysis (4) 4
neoadjuvant therapy (4) 4
radiation therapy (4) 4
radionuclide imaging (4) 4
radiopharmaceuticals - pharmacokinetics (4) 4
suv (4) 4
toxicity (4) 4
tumor (4) 4
vorhersage (4) 4
young adult (4) 4
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
adjuvant treatment (3) 3
biomarkers, tumor - blood (3) 3
breast neoplasms - blood (3) 3
breast neoplasms - metabolism (3) 3
brustkrebs (3) 3
ca 15-3 (3) 3
cancer therapies (3) 3
chemotherapie (3) 3
chemotherapy, adjuvant (3) 3
clinical trials (3) 3
criteria (3) 3
disease progression (3) 3
doxorubicin (3) 3
early f-18-fdg pet (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 8/2014, Volume 41, Issue 8, pp. 1525 - 1533
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 04/2018, Volume 59, Issue 4, p. 714
Kanoun et al. expresses their opinion on the review conducted by Jadvar et al. who highlight the main indications of 18F-FDG PET/CT for restaging and treatment... 
Diagnostics | Medical treatment | Oncology | Fluorine isotopes | Lymphomas | Diagnostic systems | Lymphoma | Positron emission tomography | Cancer
Journal Article
The Lancet Oncology, ISSN 1470-2045, 04/2019, Volume 20, Issue 4, pp. e190 - e190
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 3/2014, Volume 41, Issue 3, pp. 428 - 437
The objective of this study was to assess the impact on management and the prognostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography... 
Prognosis | Medicine & Public Health | Orthopedics | Oncology | Breast cancer | Nuclear Medicine | Primary staging | Imaging / Radiology | Cardiology | FDG PET/CT
Journal Article
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2014, Volume 41, Issue 11, pp. 2017 - 2022
Journal Article
Blood, ISSN 0006-4971, 05/2018, Volume 131, Issue 22, pp. 2449 - 2453
Both total metabolic tumor volume (TMTV), computed on baseline positron emission tomography (PET), and end of induction (EOI) PET are imaging biomarkers... 
POOLED ANALYSIS | RISK | HEMATOLOGY | VOLUME
Journal Article